Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 An actin-destabilizing factor is present in human plasma.

Literature DB >> 477868

An actin-destabilizing factor is present in human plasma.

C Chaponnier, R Borgia, E Rungger-Brändle, R Weil, G Gabbiani.

Abstract

Plasma and serum of humans or experimental animals contain a factor which destabilizes F-actin. The factor has no DNAse or thrombin activity and after incubation with F-actin does not modify the position of the actin band on a SDS polyacrylamide gel. Hence it probably depolymerizes F-actin.

Entities: Chemical Gene Species

Mesh：

Substances：

Year: 1979 PMID： 477868 DOI： 10.1007/bf01949928

Source DB: PubMed Journal: Experientia ISSN： 0014-4754

15 in total

1. The actin content of fibroblasts.

Authors: D Bray; C Thomas
Journal: Biochem J Date: 1975-05 Impact factor: 3.857

2. Determination of serum proteins by means of the biuret reaction.

Authors: A G GORNALL; C J BARDAWILL; M M DAVID
Journal: J Biol Chem Date: 1949-02 Impact factor: 5.157

3. Anti-actin specificity of human smooth muscle antibodies in chronic active hepatitis.

Authors: K Lidman; G Biberfeld; A Fagraeus; R Norberg; R Torstensson; G Utter; L Carlsson; J Luca; U Lindberg
Journal: Clin Exp Immunol Date: 1976-05 Impact factor: 4.330

4. The regulation of rabbit skeletal muscle contraction. I. Biochemical studies of the interaction of the tropomyosin-troponin complex with actin and the proteolytic fragments of myosin.

Authors: J A Spudich; S Watt
Journal: J Biol Chem Date: 1971-08-10 Impact factor: 5.157

5. Selective assay of monomeric and filamentous actin in cell extracts, using inhibition of deoxyribonuclease I.

Authors: I Blikstad; F Markey; L Carlsson; T Persson; U Lindberg
Journal: Cell Date: 1978-11 Impact factor: 41.582

6. Actin co-caps with concanavalin A receptors.

Authors: B H Toh; C C Hard
Journal: Nature Date: 1977-10-20 Impact factor: 49.962

7. Human smooth muscle autoantibody. Its identification as antiactin antibody and a study of its binding to "nonmuscular" cells.

Authors: G Gabbiani; G B Ryan; J P Lamelin; P Vassalli; G Majno; C A Bouvier; A Cruchaud; E F Lüscher
Journal: Am J Pathol Date: 1973-09 Impact factor: 4.307

8. Fixation of human anti-actin autoantibodies on skeletal muscle fibres.

Authors: C Chaponnier; L Kohler; G Gabbiani
Journal: Clin Exp Immunol Date: 1977-02 Impact factor: 4.330

9. Studies on the specificity of smooth-muscle antibodies.

Authors: P Andersen; J V Small; A Sobieszek
Journal: Clin Exp Immunol Date: 1976-10 Impact factor: 4.330

10. Cytoplasmic filaments and gap junctions in epithelial cells and myofibroblasts during wound healing.

Authors: G Gabbiani; C Chaponnier; I Hüttner
Journal: J Cell Biol Date: 1978-03 Impact factor: 10.539

19 in total

1. Circulating actin-gelsolin complexes following oleic acid-induced lung injury.

Authors: D B Smith; P A Janmey; S E Lind
Journal: Am J Pathol Date: 1988-02 Impact factor: 4.307

2. Role of group-specific component (vitamin D binding protein) in clearance of actin from the circulation in the rabbit.

Authors: P J Goldschmidt-Clermont; H Van Baelen; R Bouillon; T E Shook; M H Williams; A E Nel; R M Galbraith
Journal: J Clin Invest Date: 1988-05 Impact factor: 14.808

An actin-destabilizing factor is present in human plasma.

1. The actin content of fibroblasts.

2. Determination of serum proteins by means of the biuret reaction.

3. Anti-actin specificity of human smooth muscle antibodies in chronic active hepatitis.

4. The regulation of rabbit skeletal muscle contraction. I. Biochemical studies of the interaction of the tropomyosin-troponin complex with actin and the proteolytic fragments of myosin.

5. Selective assay of monomeric and filamentous actin in cell extracts, using inhibition of deoxyribonuclease I.

6. Actin co-caps with concanavalin A receptors.

7. Human smooth muscle autoantibody. Its identification as antiactin antibody and a study of its binding to "nonmuscular" cells.

8. Fixation of human anti-actin autoantibodies on skeletal muscle fibres.

9. Studies on the specificity of smooth-muscle antibodies.

10. Cytoplasmic filaments and gap junctions in epithelial cells and myofibroblasts during wound healing.

1. Circulating actin-gelsolin complexes following oleic acid-induced lung injury.

2. Role of group-specific component (vitamin D binding protein) in clearance of actin from the circulation in the rabbit.

3. Redistribution of membrane-bound and cytosolic action in rabbit polymorphonuclear leucocytes during phagocytosis.

4. Kinetic analysis of F-actin depolymerization in the presence of platelet gelsolin and gelsolin-actin complexes.

5. Role of plasma gelsolin and the vitamin D-binding protein in clearing actin from the circulation.

Review 6. The role of cytoskeletal and cytocontractile elements in pathologic processes.

7. Characterization of brevin, a serum protein that shortens actin filaments.

8. Actin-severing activity copurifies with phosphofructokinase.

9. Gelsolin modulation in epithelial and stromal cells of mammary carcinoma.

10. Actin organization and fibrin-clot retractile activity of cultured mouse fibroblasts.